Fig. 3From: YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axisThe effects of silencing and overexpressing EMI2 on the invasion ability of the bile duct cancer cells. A, B Transwell assay verified the changes in the migration abilities of shCtrl, shEMI2, Vector, and oeEMI2 groups; C Wound-healing experiment was performed to verify the cell migration rate of the cells in the four groups (*P < 0.05)Back to article page